Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Biologics and Stem Cell Research Boost the Cell Culture Market

Published: Thursday, November 15, 2012
Last Updated: Thursday, November 15, 2012
Bookmark and Share
Cell culture market expected to grow at a CAGR of 9.3% between 2011 and 2018.

Cell culture is becoming the next big pharmaceutical trend, as laboratories rush to meet demand for stem cell and biologics, states a new report by healthcare experts GBI Research.

The new report looks at cell culture, which involves the isolation of animal or plant cells, for their growth in an artificial environment where conditions such as temperature and pressure are all controlled.

Manufacturing of biopharmaceuticals involves cell culture methods, and the growing trend for biologics will boost the demand for cell culture processing.

Biopharmaceuticals are target-specific molecules which are less toxic and more effective than small molecular entities, and are in high demand for the treatment of cancer, diabetes, and arthritis, attracting the focus of many major pharmaceutical companies.

Due to their unique method of development, biopharmaceutical products are not easy to be imitated by generic forms.

R&D in the sector is largely devoted to deriving novel mechanisms of action, and increasing access to newer treatments to produce potential cures and improve the quality of life for people suffering from various diseases and conditions.

This focus helps in generating better treatment options and earning higher revenues for pharmaceutical and biotechnological companies.

The development and manufacturing of these biological products is directly related to the growing demand for cell culture.

Stem cell research also has enormous potential for cell culture.

Cell culture methods ensure standardized production and propagation of highly purified stem cells and their differentiated progeny.

Conventional therapies manage the disease symptoms, while stem cell therapies treat the cause of the disease, and from a commercial perspective this deficit of curative treatments in conventional therapies makes stem cell research a potential goldmine.

In the past few years, stem cell research has gained more importance in cancer research, though the technique still faces many unresolved risks including the uncontrolled proliferation of transplanted cells and transmission of infectious agents.

The cell culture market has more than 90% of its products manufactured by a small number of players, including EMD Millipore, Life Technologies Corporation, Sigma-Aldrich Corporation and Thermo Fisher Scientific Inc.

A significant number of small players are also entering into the market, especially in emerging countries. However, tough industry regulations limit the speed at which these companies can progress.

The cell culture process requires precise handling, with any changes affecting the safety and efficacy profile of the final product.

As a result of this, the processes used for cell culturing are constrained by strict controls, which slow down development and act as a bottleneck to progression in cell culture processing techniques.

The global cell culture market was worth $3.4 billion in 2011, and is expected to grow at a Compound Annual Growth Rate (CAGR) of 9.3% between 2011 and 2018 to reach $6.3 billion in 2018.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Global Biosimilars Market Value Could Hit $55 Billion by 2020, says GBI Research
Promising pipeline in active development and government efforts to reduce healthcare spending.
Thursday, July 02, 2015
Big Pharma Embraces Biologics
Increased uptake of biologics boosts API revenues and promote growth in the biopharmaceutical market.
Friday, November 30, 2012
Outsourcing in Asia to Shrink Japan’s Revenue Share
Pharma’s interest in outsourcing, combined with rising industrialization in India and China, will mark a drop in Japan’s share of the continent’s revenue.
Tuesday, November 06, 2012
‘Tis the Season to Be Sniffly - Seasonal Influenza Boosts Vaccines Market
Acute viral respiratory infection influenza, or flu, strikes every winter, and several nations are preparing to tackle this illness through dedicated healthcare schemes, states a new report by healthcare experts GBI Research.
Monday, October 22, 2012
World Awaits Biosimilars Boom
Biosimilars set to take a sizable chunk of the global biopharmaceuticals market by 2020, new report predicts.
Thursday, October 04, 2012
Scientific News
Faster, Cheaper Way to Produce New Antibiotics
A novel way of synthesising a promising new antibiotic has been identified by scientists at the University of Bristol.
Molecular Mechanism For Generating Specific Antibody Responses Discovered
Study could spur more ways to treat autoimmune disease, develop accurate vaccines.
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Designing Better Drugs
A rational drug engineering approach could breathe new life into drug development.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Factors Influencing Influenza Vaccine Effectiveness Uncovered
The long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited, new research suggests.
Study Finds Factors That May Influence Influenza Vaccine Effectiveness
Researchers at NIH have suggested that the long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited.
New Model to Enhance Zika Virus Research
The model will allow researchers to better understand how the virus causes disease and aid in the development of antiviral compounds and vaccines.
Improving Flu Vaccine Effectiveness
NIH study finds factors that may influence influenza vaccine effectiveness.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!